Prophylaxis of post-bronchoscopy pneumonia with antibiotics based on a risk prediction score
Not Applicable
- Conditions
- pneumonia
- Registration Number
- JPRN-UMIN000032175
- Lead Sponsor
- Tokai University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
1. Presence of active infection at bronchoscopy 2. Body temperature 37 degree Celcius or higher at bronchoscopy 3. History of antibiotic therapy within 2 weeks prior to bronchoscopy 4. History of drug allergy to beta-lactam antibiotics 5. Presence of severe renal dysfunction with eGFR less than 10 mL/min 6. Other reasons which researchers consider inadequate to include in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prevalence of post-bronchoscopy pneumonia in the cases treated with prophylactic antibiotics
- Secondary Outcome Measures
Name Time Method 1. Proportion of unexpected changes in the treatment of lung cancer within 30 days after bronchoscopy in the cases treated with prophylactic antibiotics 2. Prevalence of post-bronchoscopy pneumonia in the cases who failed to receive the scheduled treatment with prophylactic antibiotics 3. Prevalence of adverse effects of prophylactic antibiotic treatment 4. Risk factors of post-bronchoscopy pneumonia 5. Prevalence of post-bronchoscopy pneumonia in the cases treated with prophylactic antibiotics, excluding the cases examined with endobronchial ultrasonography-guide sheath method